The use of delamanid in the treatment of multidrug-resistant tuberculosis: interim policy guidance
The aim of this guidance is to provide the interim principles that should guide the use of delamanid in conjunction with WHO-recommended MDR-TB treatment. It also specifies the essential treatment and management conditions for use of this drug, in particular the patient's eligibility criteria and safety ...
Análisis Costo-Beneficio, Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico, Quimioterapia Combinada, Nitroimidazoles/uso terapéutico, Resultado del Tratamiento, Antituberculosos/uso terapéutico, Tuberculosis Pulmonar/tratamiento farmacológico, Ensayos Clínicos como Asunto, Nitroimidazoles/economía, Antituberculosos/economía